GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com


Jump to: navigation, search


You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor


Zhang, W, Yang, J, Liu, Y, Chen, X, Yu, T, Jia, J and Liu, C (2009) PR55 alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated beta-catenin dephosphorylation. J. Biol. Chem. 284:22649-56


A central question in Wnt signaling is the regulation of beta-catenin phosphorylation and degradation. Multiple kinases, including CKI alpha and GSK3, are involved in beta-catenin phosphorylation. Protein phosphatases such as PP2A and PP1 have been implicated in the regulation of beta-catenin. However, which phosphatase dephosphorylates beta-catenin in vivo and how the specificity of beta-catenin dephosphorylation is regulated are not clear. In this study, we show that PP2A regulates beta-catenin phosphorylation and degradation in vivo. We demonstrate that PP2A is required for Wnt/beta-catenin signaling in Drosophila. Moreover, we have identified PR55 alpha as the regulatory subunit of PP2A that controls beta-catenin phosphorylation and degradation. PR55 alpha, but not the catalytic subunit, PP2Ac, directly interacts with beta-catenin. RNA interference knockdown of PR55 alpha elevates beta-catenin phosphorylation and decreases Wnt signaling, whereas overexpressing PR55 alpha enhances Wnt signaling. Taken together, our results suggest that PR55 alpha specifically regulates PP2A-mediated beta-catenin dephosphorylation and plays an essential role in Wnt signaling.


PubMed PMC2755672 Online version:10.1074/jbc.M109.013698


Animals; Axin Protein; Blotting, Western; Cell Line; Cell Line, Tumor; Drosophila melanogaster; Enzyme Inhibitors/pharmacology; Glycogen Synthase Kinase 3/antagonists & inhibitors; Glycogen Synthase Kinase 3/metabolism; Humans; Immunoprecipitation; Lithium Chloride/pharmacology; Okadaic Acid/pharmacology; Phosphorylation/drug effects; Protein Binding; Protein Phosphatase 2/antagonists & inhibitors; Protein Phosphatase 2/genetics; Protein Phosphatase 2/metabolism; Protein Subunits; Pyrans/pharmacology; RNA, Small Interfering; Repressor Proteins/genetics; Repressor Proteins/metabolism; Spiro Compounds/pharmacology; beta Catenin/metabolism